Kronos Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	21.79	19.97	15.44	4.34
Revenue Growth (YoY)	12.87%	29.34%	255.95%	-
Cost of Revenue	14.92	14.93	11.4	3.45
Gross Profit	6.86	5.04	4.04	0.89
Selling, General & Admin	15.31	12.32	7.32	4.26
Operating Expenses	15.31	12.32	7.32	4.26
Operating Income	-8.45	-7.28	-3.28	-3.36
Interest Expense	-2.35	-1.43	-0.28	-0.05
Other Non Operating Income (Expenses)	-10.26	0.07	0.07	-0.11
EBT Excluding Unusual Items	-21.06	-8.65	-3.49	-3.52
Impairment of Goodwill	-0.16	-0.16	-0.49	-
Asset Writedown	-0.43	-0.02	-0.1	-
Other Unusual Items	0.48	-0.37	-	-
Pretax Income	-21.16	-9.2	-4.08	-3.52
Income Tax Expense	-	-	-0.54	-0.06
Earnings From Continuing Operations	-21.16	-9.2	-3.54	-3.46
Minority Interest in Earnings	-0.03	0.05	0	0.02
Net Income	-21.2	-9.15	-3.54	-3.44
Net Income to Common	-21.2	-9.15	-3.54	-3.44
Shares Outstanding (Basic)	21	2	2	-
Shares Outstanding (Diluted)	21	2	2	-
Shares Change (YoY)	1230.11%	0.18%	-	-
EPS (Basic)	-1.00	-5.76	-2.23	-
EPS (Diluted)	-1.00	-5.76	-2.23	-
Free Cash Flow	-4.36	-4.62	-1.65	-3.5
Free Cash Flow Per Share	-0.21	-2.91	-1.04	-
Gross Margin	31.50%	25.22%	26.15%	20.57%
Operating Margin	-38.79%	-36.47%	-21.23%	-77.56%
Profit Margin	-97.28%	-45.81%	-22.93%	-79.33%
Free Cash Flow Margin	-19.99%	-23.12%	-10.70%	-80.75%
EBITDA	-7.67	-6.39	-2.71	-3.1
EBITDA Margin	-35.23%	-31.98%	-17.52%	-71.36%
D&A For EBITDA	0.78	0.9	0.57	0.27
EBIT	-8.45	-7.28	-3.28	-3.36
EBIT Margin	-38.79%	-36.47%	-21.23%	-77.56%
Advertising Expenses	-	0.69	0.36	0.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.